Targeting Mettl8-Tcf1 axis promotes CD8+ TPEX differentiation and antitumor immunity

Journal:

Journal of Experimental Medicine

Published:

2026-05-04

DOI:

10.1084/jem.20250424

Affiliations:

7

Authors:

12

Go to article

Institutions	Authors	Share
State Key Laboratory of Immune Response and Immunotherapy, China	8.000000	0.67
Guangzhou Laboratory, China	1.333333	0.11
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.08
State Key Laboratory of Respiratory Disease (SKLRD), China	0.666667	0.06
Chongqing Medical University (CQMU), China	0.500000	0.04
Changping Laboratory, China	0.500000	0.04

Interested in Genetics?